IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Asymmetry Capital Management, L.P.

Q2 2016 Holdings

Filed 2016-08-05 | 19 holdings | $54.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Centene Corp(CNC)COM15135B101$5.9K82,13510.7%
Jazz Pharmaceuticals(JAZZ)COMG50871105$5.6K39,54010.2%
ELI Lilly & Co(LLY)COM532457108$4.6K58,9658.5%
Bio-Rad LabratoriesCOM90572207$4.4K31,0298.1%
Teva Pharmaceutical(TEVA)ADR881624209$4.2K83,5027.7%
Nevro Corp(NVROEUR)COM64157F103$3.7K50,6336.8%
Unitedhealth Group Inc(UNH)COM91324P102$3.3K23,6486.1%
Quest Diagnostics Inc(DGX)COM74834L100$2.8K34,8435.2%
Edwards Lifesciences Corp(EW)COM28176E108$2.8K28,2705.2%
Alere IncCOM01449J105$2.7K63,9054.9%
PTC Therapeutics(PTCT)COM69366J200$2.2K306,6503.9%
Incyte Corp(INCY)COM45337C102$2.0K25,5103.7%
Impax Laboratories IncCOM45256B101$2.0K70,2353.7%
Ironwood PharmaceuticalsCOM4633X108$1.6K121,3252.9%
Aerie Pharmaceuticals Inc(AERIEUR)COM00771V108$1.5K84,0262.7%
Pacira Pharmaceuticals(PCRX)COM695127100$1.4K41,7072.6%
Neurocrine Biosciences Inc(NBIX)COM64125C109$1.4K30,6712.6%
Amicus Therapeutics Inc(FOLD)COM03152W109$1.3K229,6262.3%
Synergy Pharmaceuticals IncCOM871639308$1.1K298,1902.1%